RDCA-DAP
The Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) promotes sharing existing patient-level data and encourages the standardization of new data collection.
The Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®) is an FDA-funded initiative that provides a centralized and standardized infrastructure to support and accelerate rare disease characterization, with the goal of accelerating therapy development across rare diseases.
You can find more information about RDCA-DAP here.